Novel 3D analysis using optical tissue clearing documents the evolution of murine rapidly progressive glomerulonephritis.


Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
08 2019
Historique:
received: 06 10 2018
revised: 23 01 2019
accepted: 28 02 2019
pubmed: 4 6 2019
medline: 2 10 2020
entrez: 4 6 2019
Statut: ppublish

Résumé

Recent developments in optical tissue clearing have been difficult to apply for the morphometric analysis of organs with high cellular content and small functional structures, such as the kidney. Here, we establish combinations of genetic and immuno-labelling for single cell identification, tissue clearing and subsequent de-clarification for histoimmunopathology and transmission electron microscopy. Using advanced light microscopy and computational analyses, we investigated a murine model of crescentic nephritis, an inflammatory kidney disease typified by immune-mediated damage to glomeruli leading to the formation of hypercellular lesions and the rapid loss of kidney function induced by nephrotoxic serum. Results show a graded susceptibility of the glomeruli, significant podocyte loss and capillary injury. These effects are associated with activation of parietal epithelial cells and formation of glomerular lesions that may evolve and obstruct the kidney tubule, thereby explaining the loss of kidney function. Thus, our work provides new high-throughput endpoints for the analysis of complex tissues with single-cell resolution.

Identifiants

pubmed: 31155155
pii: S0085-2538(19)30318-7
doi: 10.1016/j.kint.2019.02.034
pii:
doi:

Substances chimiques

Fluorescent Dyes 0
enhanced green fluorescent protein 0
Green Fluorescent Proteins 147336-22-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

505-516

Informations de copyright

Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Auteurs

Victor G Puelles (VG)

Department of Nephrology and Clinical Immunology, RWTH Aachen University Clinic, Aachen, Germany; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Nephrology, Monash Health, and Centre for Inflammatory Diseases, Monash University, Melbourne, Australia. Electronic address: victor.puellesrodriguez@monash.edu.

David Fleck (D)

Department of Chemosensation, RWTH Aachen University, Aachen.

Lena Ortz (L)

Department of Nephrology and Clinical Immunology, RWTH Aachen University Clinic, Aachen, Germany.

Stella Papadouri (S)

Department of Nephrology and Clinical Immunology, RWTH Aachen University Clinic, Aachen, Germany.

Thiago Strieder (T)

Department of Nephrology and Clinical Immunology, RWTH Aachen University Clinic, Aachen, Germany.

Alexander M C Böhner (AMC)

Institute of Experimental Immunology, Rheinische-Friedrichs-Wilhelms University of Bonn, Bonn, Germany.

James W van der Wolde (JW)

Development and Stem Cells Program, Monash Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Melbourne, Australia.

Michael Vogt (M)

Core Facility "Two-Photon Imaging" IZKF Aachen, RWTH University of Aachen, Aachen, Germany.

Turgay Saritas (T)

Department of Nephrology and Clinical Immunology, RWTH Aachen University Clinic, Aachen, Germany.

Christoph Kuppe (C)

Department of Nephrology and Clinical Immunology, RWTH Aachen University Clinic, Aachen, Germany.

Astrid Fuss (A)

Department of Nephrology and Clinical Immunology, RWTH Aachen University Clinic, Aachen, Germany.

Sylvia Menzel (S)

Department of Nephrology and Clinical Immunology, RWTH Aachen University Clinic, Aachen, Germany.

Barbara M Klinkhammer (BM)

Department of Nephrology and Clinical Immunology, RWTH Aachen University Clinic, Aachen, Germany; Institute of Pathology, RWTH University of Aachen, Aachen, Germany.

Gerhard Müller-Newen (G)

Institute of Biochemistry and Molecular Biology, RWTH Aachen University, Aachen, Germany.

Felix Heymann (F)

Department of Gastroenterology, RWTH University of Aachen, Aachen, Germany.

Leon Decker (L)

Department of Nephrology and Clinical Immunology, RWTH Aachen University Clinic, Aachen, Germany.

Fabian Braun (F)

III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Oliver Kretz (O)

III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Tobias B Huber (TB)

III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Etsuo A Susaki (EA)

Department of Systems Pharmacology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Laboratory for Synthetic Biology, RIKEN Quantitative Biology Center, Osaka, Japan; PRESTO, Japan Science and Technology Agency, Saitama, Japan.

Hiroki R Ueda (HR)

Department of Systems Pharmacology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Laboratory for Synthetic Biology, RIKEN Quantitative Biology Center, Osaka, Japan.

Peter Boor (P)

Department of Nephrology and Clinical Immunology, RWTH Aachen University Clinic, Aachen, Germany; Institute of Pathology, RWTH University of Aachen, Aachen, Germany.

Jürgen Floege (J)

Department of Nephrology and Clinical Immunology, RWTH Aachen University Clinic, Aachen, Germany.

Rafael Kramann (R)

Department of Nephrology and Clinical Immunology, RWTH Aachen University Clinic, Aachen, Germany.

Christian Kurts (C)

Institute of Experimental Immunology, Rheinische-Friedrichs-Wilhelms University of Bonn, Bonn, Germany.

John F Bertram (JF)

Development and Stem Cells Program, Monash Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Melbourne, Australia.

Marc Spehr (M)

Department of Chemosensation, RWTH Aachen University, Aachen.

David J Nikolic-Paterson (DJ)

Department of Nephrology, Monash Health, and Centre for Inflammatory Diseases, Monash University, Melbourne, Australia.

Marcus J Moeller (MJ)

Department of Nephrology and Clinical Immunology, RWTH Aachen University Clinic, Aachen, Germany; Interdisciplinary Centre for Clinical Research (IZKF Aachen), RWTH Aachen University Hospital, Aachen, Germany; Heisenberg Chair for Preventive and Translational Nephrology, Division of Nephrology, RWTH Aachen University, Aachen, Germany. Electronic address: mmoler@ukaachen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH